AC-201 tablets

AC-201 · Accro Bioscience (Suzhou) Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AC-201 tablets, covering 2025-05-22 to 2025-05-22. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II Clinical Study of AC-201 Tablets in Subjects With Plaque Psoriasis [Phase 2]